Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
about
Potential roles of BMP9 in liver fibrosisSrc-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatmentThe imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionThe Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary CirrhosisMicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.Mechanisms of fibrosis in acute liver failure.Bacterial translocation aggravates CCl4-induced liver cirrhosis by regulating CD4+ T cells in ratsImproving clinical outcomes of chronic hepatitis B virus infection.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.Immune regulation in chronic hepatitis C virus infection.Changes in liver stiffness and its associated factors during oral antiviral therapy in Chinese patients with chronic hepatitis B.Unmet Needs in Clinical and Basic Hepatitis B Virus Research.Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study.Pathological process of liver sinusoidal endothelial cells in liver diseases.Relationship between hepatic progenitor cells and stellate cells in chronic hepatitis C genotype 4.Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysis.Pirfenidone reduces subchondral bone loss and fibrosis after murine knee cartilage injury.Balancing effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R axis and ACE2-Ang-(1-7)-Mas axis in rats with CCl4-induced hepatic fibrosis.Microarray analysis for the identification of specific proteins and functional modules involved in the process of hepatocellular carcinoma originating from cirrhotic liver.Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways.
P2860
Q26998823-2B17C019-F7F6-48A8-8531-5E5BD789C073Q33687809-F600B1C7-0F98-4211-9155-35B3FEA904BAQ33745110-5AE45689-C5DE-4B97-868D-5AE1E345CC92Q33831012-027948A8-9F4B-4E0C-9544-CCB2F6321DECQ35740334-50907E69-8078-42F1-AEF8-792CAAE3C1AAQ37026138-0FA0DE01-0DDE-41D7-A970-1F82BF48EC42Q37134499-F014959A-3FEF-47E7-B575-3B4C0A1B34E4Q37257361-C0D72AE7-AD66-4DD6-8272-D8DDF479AE49Q37612290-F32F568B-36C9-4493-9C40-85BB117477D9Q38252962-9493EF87-BF27-44E6-B06E-B6DED60E092EQ38568853-74AF02DE-AE5D-482A-BB72-A9862ED1A89EQ38902559-7F689725-6316-4610-A149-761A09140CD1Q40224308-7D2278FE-A7C5-4C81-A361-D3A99B077366Q45324577-69A46FE5-B997-4CB5-8547-1E6EEA3C442DQ47111287-DEA5FBAD-922B-4F74-88F9-5243435642B2Q47140147-5E36842E-6898-4C2A-A6D4-7F428D0FBA3FQ47385040-F1AF4800-EAC8-47F6-BB73-0A8AE68BB4DFQ47450466-1709C5A4-07C3-442A-A394-8B4D7FFC3BEBQ47990145-53BA750C-5009-4DC8-AE66-D3A231289D22Q48506246-5382DD41-BCCF-4D99-8547-D078ACE0C549Q50047802-F26591B6-97C9-4E6A-9FE6-040829D90C7AQ54454817-F5A48926-81E3-4DF4-9C26-4221A61003A4Q55408871-913AD952-2E0B-489C-910F-A54871A8335E
P2860
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@ast
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@en
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@nl
type
label
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@ast
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@en
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@nl
prefLabel
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@ast
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@en
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@nl
P2093
P2860
P50
P3181
P356
P1476
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.
@en
P2093
Chun-Jen Liu
Jia-Horng Kao
Tung-Hung Su
P2860
P304
10578-10604
P3181
P356
10.3390/IJMS150610578
P407
P5008
P577
2014-06-12T00:00:00Z